2021-2031年北美微生物CRO服務市場報告:範圍、細分、動態和競爭分析
市場調查報告書
商品編碼
1871484

2021-2031年北美微生物CRO服務市場報告:範圍、細分、動態和競爭分析

North America Microbiology CRO Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: | 出版商: The Insight Partners | 英文 133 Pages | 訂單完成後即時交付

價格

預計北美微生物學合約研究組織 (CRO) 服務市場將顯著成長,到 2031 年將達到約 49.5288 億美元,高於 2023 年的 24.8824 億美元。這一成長代表著 2023 年至 2031 年 9.0% 的年複合成長率(CAGR)。

執行摘要和市場分析

北美微生物CRO服務市場正穩步成長,這得益於生物技術和藥物研發的進步,以及外包專業實驗室功能的趨勢日益成長。微生物CRO提供抗菌藥物效力測試、無菌測試、環境監測和微生物組分析等關鍵服務,這些服務對於藥物開發、醫療器材測試和生物製藥生產至關重要。該地區擁有完善的監管架構、眾多大型製藥公司以及對生命科學創新的高度重視,為CRO的發展創造了有利環境。此外,對生物製劑和疫苗的日益關注,以及傳染病發病率的上升,進一步增加了對可靠的微生物檢測和驗證服務的需求。製藥公司與CRO之間的合作提高了研發效率,加快了產品上市速度,並確保符合FDA和加拿大衛生部等監管機構制定的嚴格品質標準,從而鞏固了北美在微生物研究外包領域的領先地位。

市場區隔分析

北美微生物CRO服務市場可依應用程式、服務類型、微生物和最終用戶進行細分:

  • 應用領域:市場分為臨床、醫療器材和其他應用領域,其中臨床領域在 2023 年佔據最大的市場佔有率。
  • 服務類型:該市場分為檢測開發、客製化病毒原液生產、微生物檢測等,其中微生物檢測在 2023 年佔據最大佔有率。
  • 微生物:此分類包括細菌、真菌、病毒和寄生蟲,其中細菌在 2023 年將成為主要類別。
  • 最終用戶:市場分為生物技術和製藥公司、醫療器材公司和其他公司,其中生物技術和製藥公司在 2023 年佔據最大佔有率。

市場展望

專注於微生物檢測的合約研究組織(CRO)擴大與各利益相關者建立合作關係,以拓展其服務範圍。值得注意的是,在生物製藥需求不斷成長的推動下,2022年和2023年合作活動激增,主要集中在收購、生產協議和產品開發方面。例如,2023年8月,Frontage Laboratories, Inc.及其子公司Frontage Canada, Inc.收購了提供一系列服務的CRO公司Nucro-Technics Inc.。同樣,2022年10月,知名醫療技術CRO公司NAMSA收購了總部位於英國的客製化微生物服務實驗室Perfectus Biomed Group,從而擴大了NAMSA在多個地區的業務範圍。

國家概況

北美微生物CRO服務市場涵蓋美國、加拿大和墨西哥,其中美國在2023年佔據最大的市場佔有率。美國被公認為全球最大的微生物CRO市場,預計在整個預測期內將保持這一地位。美國市場的成長歸功於CRO對先進技術的應用、臨床試驗數量的增加以及製藥和生物技術公司對研發投入的增加。市場參與者的策略性舉措也是推動成長的關鍵因素。例如,2024年2月,ICON plc收購了Clinical Research Management, Inc. (ClinicalRM),後者為美國各政府機構提供全面的研究解決方案,從而增強了它們在傳染病和疫苗研發方面的能力。

在預測期內,美國微生物CRO市場預計將會成長,這主要得益於CRO微生物檢測服務的拓展。例如,Microbiologics於2021年4月擴展了其病毒學服務,以支援藥物和疫苗研究人員,並投資新建了一座生物安全3級(BSL-3)實驗室,以增強其對包括COVID-19在內的高傳染性病原體的檢測能力。

公司簡介

微生物CRO服務市場的主要參與者包括Microbiologics、Melbec Microbiology、Emery Pharma、TheraIndx Lifesciences Pvt. Ltd.、AVERIN BIOTECH、Statens Serum Institut、ImQuest BioSciences、PACIFIC BIOLABS、Innovotech Inc.和BluTest Laboratories Ltd.。這些公司正在採用各種策略,例如擴張、產品創新以及併購,以增強其產品和服務並提高市場佔有率。

目錄

第1章:引言

第2章:執行概要

  • 關鍵見解

第3章:研究方法

  • 二手研究
  • 初步研究
    • 假設的提出:
    • 宏觀經濟因素分析:
    • 發展基礎數字:
    • 數據三角測量:
    • 國家層面資料:

第4章:北美微生物CRO市場-主要市場動態

  • 市場促進因素
    • 大量臨床試驗外包做法日益普遍
    • 研發投入激增
  • 市場限制
    • 熟練專業人員短缺
  • 市場機遇
    • 微生物檢測技術的進步
  • 未來趨勢
    • 與服務提供者的夥伴關係和合作日益增多
  • 駕駛員和安全帶的影響:

第5章:微生物CRO市場-北美分析

  • 2021-2031年北美微生物CRO市場收入
  • 北美微生物CRO市場預測分析

第6章:北美微生物CRO市場分析-依應用領域分類

  • 臨床
  • 醫療器材
  • 其他

第7章:北美微生物學CRO市場分析-依服務類型分類

  • 檢測方法開發
  • 客製化病毒式傳播材料製作
  • 微生物檢測
  • 其他

第8章:北美微生物CRO市場分析-依微生物分類

  • 細菌
  • 真菌
  • 病毒
  • 寄生蟲

第9章:北美微生物CRO市場分析-依最終用戶分類

  • 生物技術和製藥公司
  • 醫療器材公司
  • 其他

第10章:北美微生物CRO市場-國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第11章:微生物CRO服務市場-產業概況

  • 概述
  • 微生物CRO服務市場成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第12章:公司簡介

  • Microbiologics
  • Melbec Microbiology
  • Emery Pharma
  • TheraIndx Lifesciences Pvt. Ltd.
  • AVERIN BIOTECH
  • Statens Serum Institut
  • ImQuest BioSciences
  • PACIFIC BIOLABS
  • Innovotech Inc.
  • BluTest Laboratories Ltd

第13章:附錄

Product Code: BMIRE00032141

The North America microbiology Contract Research Organization (CRO) services market is projected to grow significantly, reaching approximately US$ 4,952.88 million by 2031, up from US$ 2,488.24 million in 2023. This growth represents a compound annual growth rate (CAGR) of 9.0% from 2023 to 2031.

Executive Summary and Market Analysis

The microbiology CRO services market in North America is experiencing steady growth, fueled by advancements in biotechnology and pharmaceutical research, as well as an increasing trend towards outsourcing specialized laboratory functions. Microbiology CROs play a vital role by offering essential services such as antimicrobial efficacy testing, sterility testing, environmental monitoring, and microbiome analysis, which are crucial for drug development, medical device testing, and biopharmaceutical production. The region benefits from a robust regulatory framework, the presence of major pharmaceutical companies, and a strong emphasis on innovation in life sciences, creating a conducive environment for CRO growth. Furthermore, the rising focus on biologics and vaccines, along with the increasing incidence of infectious diseases, has amplified the demand for dependable microbiological testing and validation services. Collaborations between pharmaceutical firms and CROs are enhancing research efficiency, speeding up time-to-market, and ensuring compliance with stringent quality standards set by regulatory bodies like the FDA and Health Canada, thereby solidifying North America's leadership in outsourced microbiology research.

Market Segmentation Analysis

The North America microbiology CRO services market can be segmented based on application, service type, microorganisms, and end users:

  • Application: The market is divided into clinical, medical device, and other applications, with the clinical segment holding the largest market share in 2023.
  • Service Type: This market is categorized into assay development, custom viral stock production, microbial testing, and others, where microbial testing accounted for the largest share in 2023.
  • Microorganisms: The segmentation includes bacteria, fungi, viruses, and parasites, with bacteria being the dominant category in 2023.
  • End Users: The market is segmented into biotech and pharmaceutical companies, medical device companies, and others, with biotech and pharmaceutical companies holding the largest share in 2023.

Market Outlook

CROs specializing in microbial testing have increasingly formed partnerships with various stakeholders to broaden their service offerings. Notably, partnership activities surged in 2022 and 2023, focusing on acquisitions, manufacturing agreements, and product development, driven by the rising demand for biopharmaceuticals. For instance, in August 2023, Frontage Laboratories, Inc. and its subsidiary Frontage Canada, Inc. acquired Nucro-Technics Inc., a CRO that provides a range of services. Similarly, in October 2022, NAMSA, a prominent MedTech CRO, acquired Perfectus Biomed Group, a UK-based laboratory specializing in customized microbiological services, thereby expanding NAMSA's reach across multiple regions.

Country Insights

The North America microbiology CRO services market includes the US, Canada, and Mexico, with the US holding the largest market share in 2023. The US is recognized as the largest microbiology CRO market globally and is expected to maintain this position throughout the forecast period. The growth in the US market is attributed to the adoption of advanced technologies by CROs, an increasing number of clinical trials, and heightened investment in research and development by pharmaceutical and biotechnology companies. Strategic initiatives by market players are also pivotal in driving growth. For example, in February 2024, ICON plc acquired Clinical Research Management, Inc. (ClinicalRM), which provides comprehensive research solutions to various US government agencies, enhancing their capabilities in infectious diseases and vaccine development.

During the forecast period, the US microbiology CRO market is anticipated to grow, particularly due to the expansion of microbial testing services by CROs. For instance, Microbiologics expanded its virology services in April 2021 to support drug and vaccine researchers, investing in a new biosafety Level 3 (BSL-3) facility to enhance its capabilities in testing for highly infectious pathogens, including COVID-19.

Company Profiles

Key players in the microbiology CRO services market include Microbiologics, Melbec Microbiology, Emery Pharma, TheraIndx Lifesciences Pvt. Ltd., AVERIN BIOTECH, Statens Serum Institut, ImQuest BioSciences, PACIFIC BIOLABS, Innovotech Inc., and BluTest Laboratories Ltd. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. North America Microbiology CRO Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Practice of Outsourcing Clinical Studies with Massive Number of Trials
    • 4.1.2 Surging Research and Development Investments
  • 4.2 Market Restraints
    • 4.2.1 Shortage of Skilled Professionals
  • 4.3 Market Opportunities
    • 4.3.1 Advancements in Microbiology Testing Technology
  • 4.4 Future Trends
    • 4.4.1 Rise in Partnerships and Collaborations with Service Providers
  • 4.5 Impact of Drivers and Restraints:

5. Microbiology CRO Market - North America Analysis

  • 5.1 North America Microbiology CRO Market Revenue (US$ Million), 2021-2031
  • 5.2 North America Microbiology CRO Market Forecast Analysis

6. North America Microbiology CRO Market Analysis - by Application

  • 6.1 Clinical
    • 6.1.1 Overview
    • 6.1.2 Clinical: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Medical Device
    • 6.2.1 Overview
    • 6.2.2 Medical Device: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Others
    • 6.3.1 Overview
    • 6.3.2 Others: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. North America Microbiology CRO Market Analysis - by Service Type

  • 7.1 Assay Development
    • 7.1.1 Overview
    • 7.1.2 Assay Development: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Custom Viral Stock Production
    • 7.2.1 Overview
    • 7.2.2 Custom Viral Stock Production: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Microbial Testing
    • 7.3.1 Overview
    • 7.3.2 Microbial Testing: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Microbiology CRO Market Analysis - by Microorganisms

  • 8.1 Bacteria
    • 8.1.1 Overview
    • 8.1.2 Bacteria: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Fungi
    • 8.2.1 Overview
    • 8.2.2 Fungi: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Viruses
    • 8.3.1 Overview
    • 8.3.2 Viruses: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Parasite
    • 8.4.1 Overview
    • 8.4.2 Parasite: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Microbiology CRO Market Analysis - by End User

  • 9.1 Biotech and Pharmaceutical Companies
    • 9.1.1 Overview
    • 9.1.2 Biotech and Pharmaceutical Companies: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Medical Device Companies
    • 9.2.1 Overview
    • 9.2.2 Medical Device Companies: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Microbiology CRO Market - Country Analysis

  • 10.1 North America
    • 10.1.1 North America Microbiology CRO Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 North America Microbiology CRO Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 United States: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 United States: North America Microbiology CRO Market Share - by Application
        • 10.1.1.2.2 United States: North America Microbiology CRO Market Share - by Clinical
        • 10.1.1.2.3 United States: North America Microbiology CRO Market Share - by Infectious Diseases
        • 10.1.1.2.4 United States: North America Microbiology CRO Market Share - by Service Type
        • 10.1.1.2.5 United States: North America Microbiology CRO Market Share - by Microbial Testing
        • 10.1.1.2.6 United States: North America Microbiology CRO Market Share - by Microorganisms
        • 10.1.1.2.7 United States: North America Microbiology CRO Market Share - by End User
      • 10.1.1.3 Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Canada: North America Microbiology CRO Market Share - by Application
        • 10.1.1.3.2 Canada: North America Microbiology CRO Market Share - by Clinical
        • 10.1.1.3.3 Canada: North America Microbiology CRO Market Share - by Infectious Diseases
        • 10.1.1.3.4 Canada: North America Microbiology CRO Market Share - by Service Type
        • 10.1.1.3.5 Canada: North America Microbiology CRO Market Share - by Microbial Testing
        • 10.1.1.3.6 Canada: North America Microbiology CRO Market Share - by Microorganisms
        • 10.1.1.3.7 Canada: North America Microbiology CRO Market Share - by End User
      • 10.1.1.4 Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 Mexico: North America Microbiology CRO Market Share - by Application
        • 10.1.1.4.2 Mexico: North America Microbiology CRO Market Share - by Clinical
        • 10.1.1.4.3 Mexico: North America Microbiology CRO Market Share - by Infectious Diseases
        • 10.1.1.4.4 Mexico: North America Microbiology CRO Market Share - by Service Type
        • 10.1.1.4.5 Mexico: North America Microbiology CRO Market Share - by Microbial Testing
        • 10.1.1.4.6 Mexico: North America Microbiology CRO Market Share - by Microorganisms
        • 10.1.1.4.7 Mexico: North America Microbiology CRO Market Share - by End User

11. Microbiology CRO Services Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Microbiology CRO Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Microbiologics
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Melbec Microbiology
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Emery Pharma
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 TheraIndx Lifesciences Pvt. Ltd.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 AVERIN BIOTECH
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Statens Serum Institut
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 ImQuest BioSciences
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 PACIFIC BIOLABS
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Innovotech Inc.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 BluTest Laboratories Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Microbiology CRO Market Segmentation
  • Table 2. Research and Development Investments by Major Pharmaceutical Companies
  • Table 3. North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 4. North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Type
  • Table 6. North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Microorganisms
  • Table 7. North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 8. North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 9. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 10. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Clinical
  • Table 11. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Diseases
  • Table 12. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 13. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Microbial Testing
  • Table 14. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Microorganisms
  • Table 15. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 16. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 17. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Clinical
  • Table 18. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Diseases
  • Table 19. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 20. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Microbial Testing
  • Table 21. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Microorganisms
  • Table 22. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 23. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 24. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Clinical
  • Table 25. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Diseases
  • Table 26. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 27. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Microbial Testing
  • Table 28. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Microorganisms
  • Table 29. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 30. Recent Organic Growth Strategies in Microbiology CRO Services Market
  • Table 31. Recent Inorganic Growth Strategies in the Microbiology CRO Services Market
  • Table 32. Glossary of Terms, Microbiology CRO Services Market

List Of Figures

  • Figure 1. North America Microbiology CRO Market Segmentation - Country
  • Figure 2. North America Microbiology CRO Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Microbiology CRO Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Microbiology CRO Market Share (%) - by Application (2023 and 2031)
  • Figure 6. Clinical: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Medical Device: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Others: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. North America Microbiology CRO Market Share (%) - by Service Type (2023 and 2031)
  • Figure 10. Assay Development: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Custom Viral Stock Production: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Microbial Testing: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Others: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. North America Microbiology CRO Market Share (%) - by Microorganisms (2023 and 2031)
  • Figure 15. Bacteria: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Fungi: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Viruses: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Parasite: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. North America Microbiology CRO Market Share (%) - by End User (2023 and 2031)
  • Figure 20. Biotech and Pharmaceutical Companies: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Medical Device Companies: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Others: North America Microbiology CRO Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. North America Microbiology CRO Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 24. United States: North America Microbiology CRO Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. Canada: North America Microbiology CRO Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Mexico: North America Microbiology CRO Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. Growth Strategies in Microbiology CRO Services Market